B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

HKDC1

MOLECULAR TARGET

hexokinase domain containing 1

UniProt: Q2TB90NCBI Gene: 802012 compounds

HKDC1 (hexokinase domain containing 1) is targeted by 2 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).

Compounds Targeting HKDC1

Ranked by bioassay confidence score (PubChem active assay count × evidence quality).

#CompoundConfidenceActive Assays
1Chlorhexidine1.393
2Methylene Blue0.691

About HKDC1 as a Drug Target

HKDC1 (hexokinase domain containing 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 2 compounds with documented HKDC1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.

HKDC1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.